Language Select
Varian Logo

Press Releases

Oktober 21, 2018
During its Users Meeting at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting, Varian (NYSE: VAR) shared details of its development work on an artificial intelligence... Read more
Oktober 21, 2018
Varian (NYSE: VAR) today announced the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments. Based on over five years of in-clinic research, Bravos is an integrated... Read more
Oktober 20, 2018
To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of its clinical partners, Maryland Proton Treatment Center and Cincinnati... Read more
Oktober 20, 2018
Varian (NYSE: VAR) today announced its new single-room proton therapy system, ProBeam® 360°. With a 30 percent smaller footprint than the previous system, ProBeam 360° offers uncompromised... Read more
Oktober 12, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported... Read more
Oktober 04, 2018
Varian (NYSE: VAR) today announced it has signed an educational partnership with one of India's leading hospital groups to provide greater access to training in advanced radiotherapy and... Read more
Oktober 03, 2018
Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as president of Proton Solutions, the division formerly... Read more
Oktober 01, 2018
Varian (NYSE: VAR) today announced a 75-year-old male with throat cancer was the first patient in India to be treated on the Halcyon™ system at Sterling Cancer Hospital in Gujarat. Halcyon... Read more
September 20, 2018
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the... Read more
September 12, 2018
Varian (NYSE: VAR) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com